Variant report

Variant	esv12593
Chromosome Location	chr11:56946787-56948827
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:17)
CpG islands
(count:183)
Chromatin interactive
region (count:2)
LncRNA
region (count:2)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:17 , 50 per page) page: 1

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CTBP2	chr11:56947016-56949186	H1-hESC	embryonic stem cell:	n/a	n/a
2	CTCF	chr11:56947900-56948050	WERI-Rb-1	eye:	n/a	chr11:56947924-56947932
3	E2F6	chr11:56947513-56948451	H1-hESC	embryonic stem cell:	n/a	n/a
4	E2F6	chr11:56947722-56948358	H1-hESC	embryonic stem cell:	n/a	n/a
5	FOXA1	chr11:56948447-56948707	T-47D	breast:	n/a	chr11:56948608-56948623
6	FOXA1	chr11:56948445-56948730	T-47D	breast:	n/a	chr11:56948608-56948623
7	FOXA2	chr11:56948478-56948860	A549	lung:	n/a	n/a
8	FOXA2	chr11:56948428-56948808	A549	lung:	n/a	n/a
9	GTF2F1	chr11:56947838-56947912	H1-hESC	embryonic stem cell:	n/a	n/a
10	MAX	chr11:56947678-56948277	H1-hESC	embryonic stem cell:	n/a	chr11:56947950-56947960
11	MAX	chr11:56947690-56948393	H1-hESC	embryonic stem cell:	n/a	chr11:56947950-56947960
12	POLR2A	chr11:56947504-56948201	H1-neurons	neurons:	n/a	n/a
13	POLR2A	chr11:56947474-56948242	H1-neurons	neurons:	n/a	n/a
14	POLR2A	chr11:56948698-56949703	K562	blood:	n/a	n/a
15	REST	chr11:56947182-56948253	H1-neurons	neurons:	n/a	chr11:56947456-56947474 chr11:56947915-56947928 chr11:56947782-56947795 chr11:56947911-56947931
16	SIN3A	chr11:56947163-56947934	H1-hESC	embryonic stem cell:	n/a	chr11:56947890-56947899
17	ZNF143	chr11:56947186-56948247	H1-hESC	embryonic stem cell:	n/a	chr11:56947765-56947783

(count:183 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr11:56948015-56948065	HCF	heart:	n/a
2	chr11:56948018-56948068	K562	blood:	n/a
3	chr11:56947754-56947804	SK-N-SH_RA	brain:	n/a
4	chr11:56948015-56948065	SK-N-SH	brain:	n/a
5	chr11:56948015-56948065	ProgFib	skin:	n/a
6	chr11:56947754-56947804	ECC-1	luminal epithelium:	n/a
7	chr11:56948015-56948065	LNCaP	prostate:	n/a
8	chr11:56948018-56948068	NHBE	bronchial:	n/a
9	chr11:56948018-56948068	IMR90	lung:	fetal
10	chr11:56948018-56948068	AG09319	gingival:	n/a
11	chr11:56948018-56948068	MCF10A-Er-Src	breast:	n/a
12	chr11:56947754-56947804	U87	brain:	n/a
13	chr11:56947754-56947804	NHBE	bronchial:	n/a
14	chr11:56947754-56947804	HL-60	blood:	n/a
15	chr11:56948015-56948065	T-47D	breast:	n/a
16	chr11:56948015-56948065	Caco-2	colon:	n/a
17	chr11:56948015-56948065	NHBE	bronchial:	n/a
18	chr11:56948015-56948065	GM12891	blood:	n/a
19	chr11:56947754-56947804	Jurkat	blood:	n/a
20	chr11:56948018-56948068	A549	lung:	n/a
21	chr11:56948018-56948068	RPTEC	kidney:	n/a
22	chr11:56948015-56948065	H1-hESC	embryonic stem cell:	embryo
23	chr11:56948015-56948065	SK-N-SH_RA	brain:	n/a
24	chr11:56948015-56948065	CMK	blood:	n/a
25	chr11:56947754-56947804	HEEpiC	esophagus:	n/a
26	chr11:56947754-56947804	HNPCEpiC	eye:	n/a
27	chr11:56948018-56948068	SK-N-SH_RA	brain:	n/a
28	chr11:56948015-56948065	PrEC	prostate:	n/a
29	chr11:56948015-56948065	HL-60	blood:	n/a
30	chr11:56948018-56948068	GM12878	blood:	n/a
31	chr11:56948018-56948068	AG04449	skin:	fetal
32	chr11:56948015-56948065	SK-N-MC	brain:	n/a
33	chr11:56947754-56947804	T-47D	breast:	n/a
34	chr11:56948015-56948065	Hepatocyte	liver:	n/a
35	chr11:56948018-56948068	GM12891	blood:	n/a
36	chr11:56948015-56948065	NT2-D1	testis:	n/a
37	chr11:56947754-56947804	K562	blood:	n/a
38	chr11:56947754-56947804	PrEC	prostate:	n/a
39	chr11:56948018-56948068	ovcar-3	ovarian:	n/a
40	chr11:56948018-56948068	HEEpiC	esophagus:	n/a
41	chr11:56948018-56948068	H1-hESC	embryonic stem cell:	embryo
42	chr11:56947754-56947804	NH-A	brain:	n/a
43	chr11:56947754-56947804	ovcar-3	ovarian:	n/a
44	chr11:56948018-56948068	NT2-D1	testis:	n/a
45	chr11:56947754-56947804	SKMC	muscle:	n/a
46	chr11:56947754-56947804	BE2_C	brain:	n/a
47	chr11:56948018-56948068	NHDF-neo	bronchial:	n/a
48	chr11:56947754-56947804	HUVEC	blood vessel:	n/a
49	chr11:56948015-56948065	SAEC	small airway:	n/a
50	chr11:56948015-56948065	AG10803	skin:	n/a

(count:2 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr11:56946370..56948285-chr11:56958607..56960284,2	MCF-7	breast:
2	chr11:56945716..56947687-chr11:56952025..56954655,2	K562	blood:

(count:2 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-LRRC55-1	chr11:56947536-56947757	NONHSAT021402
2	lnc-LRRC55-1	chr11:56948622-56948750	NONHSAT021402

No data

Variant related genes	Relation type
LRRC55	TF binding region
LRRC55	CpG island

Extended variants
information (count: 73 )
Associated
traits (count: 55 )

Variant overlapped rSNPs/rCNVs (count:73 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs536802683	chr11:56946813-56946814	Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
2	rs191085844	chr11:56946829-56946830	Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs149064501	chr11:56946860-56946861	Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs143093301	chr11:56946958-56946959	Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs114406186	chr11:56946960-56946961	Bivalent/Poised TSS Bivalent Enhancer Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs183276345	chr11:56947008-56947009	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Bivalent Enhancer Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs61058019	chr11:56947063-56947064	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs559146112	chr11:56947165-56947166	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs55658978	chr11:56947190-56947191	Bivalent/Poised TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Bivalent Enhancer Flanking Active TSS	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
10	rs368222787	chr11:56947204-56947205	Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs563172723	chr11:56947205-56947206	Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs528599999	chr11:56947338-56947339	Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs530697934	chr11:56947352-56947353	Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs552016984	chr11:56947371-56947372	Bivalent/Poised TSS Active TSS Enhancers Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs542682471	chr11:56947411-56947412	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs372050219	chr11:56947415-56947416	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs532354049	chr11:56947447-56947448	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs376719885	chr11:56947454-56947455	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs12808495	chr11:56947463-56947464	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
20	rs117084494	chr11:56947468-56947469	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs2077190	chr11:56947528-56947529	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
22	rs187801693	chr11:56947542-56947543	Bivalent/Poised TSS Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
23	rs2077188	chr11:56947647-56947648	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region lncRNA	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
24	rs537664175	chr11:56947666-56947667	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
25	rs531266319	chr11:56947667-56947668	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
26	rs79110650	chr11:56947673-56947674	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
27	rs534317260	chr11:56947681-56947682	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
28	rs552981910	chr11:56947706-56947707	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
29	rs367588653	chr11:56947710-56947711	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
30	rs574174978	chr11:56947746-56947747	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region lncRNA	1 gene(s)	Overlapped CNVs	n/a
31	rs2077189	chr11:56947790-56947791	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
32	rs116451622	chr11:56947803-56947804	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
33	rs561439482	chr11:56947902-56947903	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs545979287	chr11:56947911-56947912	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs151165753	chr11:56947933-56947934	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs547276076	chr11:56947948-56947949	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs528425711	chr11:56947952-56947953	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs140341923	chr11:56947956-56947957	Bivalent/Poised TSS Active TSS Bivalent Enhancer Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs547470176	chr11:56948007-56948008	Bivalent/Poised TSS Enhancers Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs74982295	chr11:56948025-56948026	Bivalent/Poised TSS Enhancers Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
41	rs530134626	chr11:56948043-56948044	Bivalent/Poised TSS Enhancers Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
42	rs548675011	chr11:56948073-56948074	Bivalent/Poised TSS Enhancers Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs192289469	chr11:56948074-56948075	Bivalent/Poised TSS Enhancers Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs368804995	chr11:56948127-56948128	Bivalent/Poised TSS Enhancers Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs552779852	chr11:56948141-56948142	Bivalent/Poised TSS Enhancers Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs145451393	chr11:56948167-56948168	Bivalent/Poised TSS Enhancers Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh Bivalent Enhancer	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs535358649	chr11:56948201-56948202	Bivalent/Poised TSS Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs147813868	chr11:56948212-56948213	Bivalent/Poised TSS Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs3082154	chr11:56948225-56948226	Bivalent/Poised TSS Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs202192384	chr11:56948226-56948227	Bivalent/Poised TSS Enhancers Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:55)

Disease	PMID	Source
Wilms tumour	21544195	CNVD
Medulloblastoma	21979893	CNVD
Gastric cancer	17908304	CNVD
Multiple myeloma	20724749	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Autism	22495311	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Non-small cell lung cancer	21385341	CNVD
Intellectual disability	22102821	CNVD
Renal cell carcinoma	18194544	CNVD
Glioblastoma multiforme	21138945	CNVD
Prostate cancer	18632612	CNVD
Esophageal cancer	21851588	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Glioblastoma multiforme	22286061	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	21637783	CNVD
Acute myeloid leukemia	16864856	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	21484798	CNVD
Ewing''s sarcoma	21437220	CNVD
Oral cancer	21386901	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	20837533	CNVD
Breast cancer	21264507	CNVD
Cervical cancer	21063398	CNVD
Glioblastoma multiforme	19960244	CNVD
Liposarcoma	21253554	CNVD
Neuroblastoma	18923524	CNVD
Neuroblastoma	18664255	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Multiple myeloma	17077331	CNVD
Neuroblastoma	17533364	CNVD
Breast cancer	21364760	CNVD
Lung cancer	18438408	CNVD
small cell lung cancer	20016488	CNVD
Colorectal cancer	16272173	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Pituitary adenoma	18645599	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Myelofibrosis	22110671	CNVD
Glioblastoma multiforme	21080181	CNVD
Smith-Lemli-Opitz syndrome	21572526	CNVD
Multiple myeloma	16461302	CNVD
Cancer	16751803	CNVD
Seminomas	18059402	CNVD
Autism	22495309	CNVD
Autism	20808228	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Breast cancer	17142309	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:146 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:56946200-56947800	Enhancers	Fetal Brain Male	brain
2	chr11:56946400-56947400	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
3	chr11:56946600-56946800	Bivalent Enhancer	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
4	chr11:56946600-56946800	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
5	chr11:56946600-56946800	Enhancers	Stomach Mucosa	stomach
6	chr11:56946600-56947000	Bivalent Enhancer	iPS-18 Cell Line	embryonic stem cell
7	chr11:56946600-56947200	Flanking Active TSS	Fetal Brain Female	brain
8	chr11:56946600-56948600	Enhancers	Pancreas	Pancrea
9	chr11:56946800-56947000	Bivalent Enhancer	H1 Cell Line	embryonic stem cell
10	chr11:56946800-56947200	Bivalent/Poised TSS	ES-WA7 Cell Line	embryonic stem cell
11	chr11:56946800-56947200	Flanking Bivalent TSS/Enh	iPS-15b Cell Line	embryonic stem cell
12	chr11:56946800-56947200	Bivalent Enhancer	iPS DF 6.9 Cell Line	embryonic stem cell
13	chr11:56946800-56947200	Bivalent Enhancer	ES-UCSF4 Cell Line	embryonic stem cell
14	chr11:56946800-56948600	Bivalent/Poised TSS	ES-I3 Cell Line	embryonic stem cell
15	chr11:56947000-56947200	Flanking Bivalent TSS/Enh	H1 Cell Line	embryonic stem cell
16	chr11:56947000-56947200	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
17	chr11:56947000-56947200	Bivalent Enhancer	HUES48 Cell Line	embryonic stem cell
18	chr11:56947000-56947200	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
19	chr11:56947000-56947200	Flanking Bivalent TSS/Enh	iPS-20b Cell Line	embryonic stem cell
20	chr11:56947000-56947200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
21	chr11:56947000-56947200	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
22	chr11:56947000-56947200	Bivalent Enhancer	Brain Germinal Matrix	brain
23	chr11:56947000-56947400	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
24	chr11:56947000-56947400	Enhancers	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
25	chr11:56947000-56947400	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
26	chr11:56947000-56947600	Bivalent Enhancer	Fetal Adrenal Gland	Adrenal Gland
27	chr11:56947000-56947800	Bivalent Enhancer	Fetal Stomach	stomach
28	chr11:56947000-56948200	Bivalent/Poised TSS	iPS-18 Cell Line	embryonic stem cell
29	chr11:56947000-56948400	Active TSS	H9 Cell Line	embryonic stem cell
30	chr11:56947000-56948400	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
31	chr11:56947200-56947400	Bivalent Enhancer	Ganglion Eminence derived primary cultured neurospheres	brain
32	chr11:56947200-56947400	Flanking Bivalent TSS/Enh	Brain Germinal Matrix	brain
33	chr11:56947200-56947600	Flanking Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
34	chr11:56947200-56947600	Active TSS	ES-UCSF4 Cell Line	embryonic stem cell
35	chr11:56947200-56948000	Active TSS	ES-WA7 Cell Line	embryonic stem cell
36	chr11:56947200-56948200	Bivalent/Poised TSS	HUES6 Cell Line	embryonic stem cell
37	chr11:56947200-56948200	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
38	chr11:56947200-56948200	Bivalent/Poised TSS	iPS DF 6.9 Cell Line	embryonic stem cell
39	chr11:56947200-56948400	Bivalent/Poised TSS	H1 Cell Line	embryonic stem cell
40	chr11:56947200-56948400	Bivalent/Poised TSS	HUES48 Cell Line	embryonic stem cell
41	chr11:56947200-56948400	Bivalent/Poised TSS	iPS-20b Cell Line	embryonic stem cell
42	chr11:56947200-56948400	Active TSS	Fetal Brain Female	brain
43	chr11:56947200-56948600	Bivalent/Poised TSS	Brain Inferior Temporal Lobe	brain
44	chr11:56947400-56947800	Bivalent/Poised TSS	Brain Hippocampus Middle	brain
45	chr11:56947400-56947800	Bivalent Enhancer	Fetal Muscle Leg	muscle
46	chr11:56947400-56948000	Flanking Active TSS	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
47	chr11:56947400-56948200	Flanking Bivalent TSS/Enh	Ganglion Eminence derived primary cultured neurospheres	brain
48	chr11:56947400-56948200	Bivalent/Poised TSS	Brain Germinal Matrix	brain
49	chr11:56947400-56948200	Active TSS	Brain Dorsolateral Prefrontal Cortex	brain
50	chr11:56947400-56948400	Flanking Active TSS	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links